The 13 most recent market catalysts affecting $TMO, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 24, 2026
Corporate Catalyst
Bullish
Impact 92
Thermo Fisher Stock Hits Record High: What's Happening?
Thermo Fisher Scientific (TMO) shares hit an all-time high of $681.55, extending gains from a strong Q2 earnings report where adjusted earnings and sales beat estimates. The compan…
Sep 22, 2026
Market Technicals
Bearish
Impact 65
Top 3 Health Care Stocks That May Keep You Up At Night This Month
The filing identifies Thermo Fisher Scientific (TMO), Moderna (MRNA), and Agilent Technologies (A) as having RSI values above 70, indicating they are technically overbought. This m…
Sep 15, 2026
Corporate Catalyst
Bullish
Impact 75
Thermo Fisher Scientific after a company executive said at an industry conference that orders are outpacing revenue, which in its view bodes well for future growth.
The executive's comment signals robust demand for Thermo Fisher's offerings, which is a strong leading indicator for future revenue. This positive outlook could boost TMO's stock p…
Sep 15, 2026
Corporate Catalyst
Bullish
Impact 65
Thermo Fisher Scientific Exec Says At Morgan Stanley Conference Orders Are Outpacing Revenue, Boding Well For Future Growth
A Thermo Fisher Scientific executive disclosed at a Morgan Stanley conference that the company is experiencing orders outpacing revenue. This is a significant positive indicator as…
Sep 3, 2026
Corporate Catalyst
Neutral
Impact 65
CLSA Initiates Coverage On Thermo Fisher Scientific with Outperform Rating, Announces Price Target of $748
CLSA's initiation of coverage on Thermo Fisher Scientific with an Outperform rating and a $748 price target is a positive development for the company. Analyst initiations, especial…
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 65
Thermo Fisher Says India Is One Of Its Fastest-Growing Markets
Thermo Fisher Scientific (TMO) is projecting 15-20% customer base growth in India over the next five years, fueled by the country's burgeoning biopharmaceutical, clean energy, and …
Jul 27, 2026
Corporate Catalyst
Neutral
Impact 55
Piper Sandler Maintains Neutral on Thermo Fisher Scientific, Raises Price Target to $600
Piper Sandler analyst David Westenberg maintained a 'Neutral' rating on Thermo Fisher Scientific but raised the price target from $510 to $600. This action suggests that while the …
Jul 24, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $650
Barclays analyst Luke Sergott maintained an 'Overweight' rating on Thermo Fisher Scientific and raised the price target from $625 to $650. This action signals continued confidence …
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 92
Thermo Fisher Points to Improving End-Market Activity
Thermo Fisher Scientific's Q2 earnings and revenue significantly surpassed analyst estimates, indicating robust performance. The company's upward revision of its full-year guidance…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
Danaher shares are trading higher amid sympathy with Thermo Fisher after that company reported better-than-expected Q2 financial results and raised its FY26 adjusted EPS guidance above estimates.
This headline indicates a significant positive catalyst for Danaher, driven by a 'sympathy' trade with Thermo Fisher. Thermo Fisher's strong Q2 results and raised FY26 EPS guidance…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
Thermo Fisher Scientific Exec Says Raising 2026 Revenue Forecast To Between $47.4B - $48.1B; Raising 2026 Adj EPS View To $24.93 - $25.33
Thermo Fisher Scientific (TMO) has raised its 2026 revenue forecast to between $47.4B - $48.1B and its adjusted EPS view to $24.93 - $25.33. This upward revision signals management…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
Thermo Fisher Scientific shares are trading higher after the company reported better-than-expected Q2 financial results.
This headline represents a significant corporate catalyst for Thermo Fisher Scientific, directly impacting its stock price positively due to strong financial performance. The bette…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 85
Thermo Fisher Scientific Q2 Adj. EPS $6.03 Beats $5.71 Estimate, Sales $11.994B Beat $11.701B Estimate
Thermo Fisher Scientific's Q2 earnings and sales significantly surpassed analyst estimates, demonstrating strong financial health and operational execution. This positive performan…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.